4-(2-羟基丙烷-2-基)苯硼酸 | 886593-45-9

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(2-羟基丙烷-2-基)苯硼酸
• 中文别名: (4-(2-羟基丙烷-2-基)苯基)硼酸
• 英文名称: (4-(2-hydroxypropan-2-yl)phenyl)boronic acid
• 英文别名: 4-(2-hydroxypropane-2-yl)phenylboronic acid；[4-(1-hydroxy-1-methylethyl)phenyl]boronic acid；[4-(2-hydroxypropan-2-yl)phenyl]boronic acid
• CAS: 886593-45-9
• 化学式: C₉H₁₃BO₃
• mdl: MFCD09992905
• 分子量: 180.011
• InChiKey: DPIDNFWCDMXMDY-UHFFFAOYSA-N

物化性质

• 沸点：
  354.4±44.0 °C(Predicted)
• 密度：
  1.16±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  60.7
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(2-Hydroxypropan-2-yl)phenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(2-Hydroxypropan-2-yl)phenylboronic acid
CAS number: 886593-45-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H13BO3
Molecular weight: 180.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(2-羟基丙烷-2-基)苯硼酸 在 四(三苯基膦)钯 、 sodium carbonate 、 caesium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 2,2,2-三氟乙醇 、 水 为溶剂， 反应 2.83h， 生成 5-(6-(4-(2-hydroxypropan-2-yl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-((tetrahydro-2H-pyran-4-yl)oxy)benzonitrile
  参考文献：
  名称：

  [EN] TANK-BINDING KINASE INHIBITOR COMPOUNDS
  [FR] COMPOSÉS INHIBITEURS DE KINASES SE LIANT À TANK

  摘要：

  揭示了具有以下化学式（I）的化合物及其使用和制备方法。

  公开号：

  WO2015187684A1
• 作为产物：
  描述：

  硼酸三异丙酯 、 2-羟基-2-(4-溴苯基)丙烷 在 正丁基锂 作用下， 以 四氢呋喃 、 hexanes 为溶剂， 反应 75.5h， 以13%的产率得到4-(2-羟基丙烷-2-基)苯硼酸
  参考文献：
  名称：

  WO2006/48727

  摘要：

  公开号：

文献信息

• [EN] HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QUE MODULATEURS DU TNF ALPHA
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2017023905A1

  公开（公告）日：2017-02-09

  Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR1 or N; B is CR3 or N; D is CR4 or N; L1 is -(CR7R7)m-; L2 is -(CR7R7)n-; and X, Z, R1, R2, R3, R4, R5,and R6 are define herein. Also disclosed are methods of using such compounds as modulators of TNFα, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

  披露了公式(I)化合物或其盐，其中：A是CR1或N；B是CR3或N；D是CR4或N；L1是-(CR7R7)m-；L2是-(CR7R7)n-；X，Z，R1，R2，R3，R4，R5和R6都在此定义。还披露了将此类化合物用作调节TNFα的调节剂的方法，以及包含此类化合物的药物组合物。这些化合物可用于治疗炎症和自身免疫性疾病。
• Ni-Catalyzed Suzuki–Miyaura Cross-Coupling of α-Oxo-vinylsulfones To Prepare <i>C</i>-Aryl Glycals and Acyclic Vinyl Ethers
  作者：Liang Gong、Hong-Bao Sun、Li-Fan Deng、Xia Zhang、Jie Liu、Shengyong Yang、Dawen Niu

  DOI：10.1021/jacs.9b02312

  日期：2019.5.15

  electrophiles in Ni-catalyzed Suzuki-Miyaura cross-coupling reactions. The C-sulfone bond in the α-oxo-vinylsulfone motif is cleaved chemoselectively in these reactions, furnishing C-aryl glycals or acyclic vinyl ethers in high yields. These reactions proceed under mild conditions and tolerate a remarkable scope of heterocycles and functional groups. Preliminary mechanistic studies revealed the importance of

  我们证明，在 Ni 催化的 Suzuki-Miyaura 交叉偶联反应中，容易获得且工作台稳定的 α-氧代乙烯基砜是有能力的亲电试剂。在这些反应中，α-氧代-乙烯基砜基序中的 C-砜键被化学选择性地裂解，以高产率提供 C-芳基乙二醇或无环乙烯基醚。这些反应在温和的条件下进行，并且可以耐受范围广泛的杂环和官能团。初步的机理研究揭示了 α-杂原子在促进这些转变中的重要性。
• 利用α-O-烯基砜作为亲电试剂的铃木反应及其应用
  申请人：四川大学

  公开号：CN111808057A

  公开（公告）日：2020-10-23

  本发明提供了一种利用α‑O‑烯基砜作为亲电试剂的Suzuki‑Miyaura偶联反应，它包括如下步骤：取α‑O‑烯基砜、有机硼试剂、配体、碱、催化剂于溶剂反应，即可。本发明还提供了该偶联反应的用途。本发明利用α‑O‑烯基砜作为亲电试剂进行Suzuki‑Miyaura偶联反应时，反应原料α‑O‑烯基砜制备简单、结构稳定，能够克服利用有机卤化物和磺酸作为Suzuki‑Miyaura偶联反应的亲电试剂时存在的不稳定、制备困难等缺点。同时，该反应的反应条件温和，能够兼容范围很广的杂环和各类官能团，同时产率高，能够实现大规模工艺生产。同时，本发明利用α‑O‑烯基砜作为亲电试剂进行Suzuki‑Miyaura偶联反应可以以高产率生成芳基糖苷和开链烯基醚，还可以制备二型糖尿病药物依格列净和2‑去氧依格列净，应用广泛。
• [EN] HETEROCYCLIC DERIVATIVES MODULATING ACTIVITY OF CERTAIN PROTEIN KINASES<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES MODULANT L'ACTIVITÉ DE CERTAINES PROTÉINES KINASES
  申请人：EUDENDRON S R L

  公开号：WO2016096709A1

  公开（公告）日：2016-06-23

  The present invention relates to novel heterocyclic derivatives having general formula (I) and their therapeutic use for diseases such as cancer, inflammation, pain, autoimmune diseases or neurodegenerative diseases like Alzheimer's or Parkinson's disease that can be treated by modulation of certain protein kinases. Compounds of formula (I) can be used for treatment of patients who do not respond to kinase inhibition therapy that comprises currently available medications.

  本发明涉及具有通式（I）的新型杂环衍生物及其在癌症、炎症、疼痛、自身免疫疾病或阿尔茨海默病、帕金森病等神经退行性疾病的治疗中的应用，这些疾病可以通过调节特定蛋白激酶来治疗。通式（I）的化合物可用于治疗对目前可用药物组成的激酶抑制疗法无反应的患者。
• [EN] PYRIDINYL BASED APOPTOSIS SIGNAL-REGULATION KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE DE RÉGULATION DU SIGNAL APOPTOTIQUE À BASE DE PYRIDINYLE
  申请人：FRONTHERA U S PHARMACEUTICALS LLC

  公开号：WO2018151830A1

  公开（公告）日：2018-08-23

  Apoptosis signal-regulating kinase 1 (ASK1) activation and signaling have been reported to play an important role in a broad range of diseases including neurodegenerative, cardiovascular, inflammatory, autoimmunity and metabolic disorders. Disclosed herein is the synthesis of pyridinyl derived therapeutic agents that function as inhibitors of ASK 1 as well as their pharmaceutical compositions and methods of use.

  细胞凋亡信号调节激酶1（ASK1）的激活和信号传导据报道在包括神经退行性、心血管、炎症、自身免疫和代谢紊乱等广泛疾病中发挥重要作用。本文披露了一种以吡啶基衍生的治疗剂的合成，其作为ASK1的抑制剂以及它们的药物组合物和使用方法。